We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $3.64B
1-Year Est. Return 83.38%
This Fund
S&P 500
This Quarter Est. Return
+49.74%
1 Year Est. Return
+83.38%
3 Year Est. Return
+239.61%
5 Year Est. Return
+330.19%
10 Year Est. Return
+1,383.86%
AUM
$3.64B
AUM Growth
+$913M
Cap. Flow
+$245M
Cap. Flow %
6.73%
Top 10 Hldgs %
40.93%
Holding
1,250
New
158
Increased
429
Reduced
585
Closed
75

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$72.2M
2
AVGO icon
Broadcom
AVGO
+$27.9M
3
SNDK
Sandisk
SNDK
+$15M
4
AAPL icon
Apple
AAPL
+$13.9M
5
MU icon
Micron Technology
MU
+$12.9M

Sector Composition

Rank Sector Weight
1 Technology 56.05%
2 Healthcare 8.58%
3 Communication Services 8.31%
4 Consumer Discretionary 7.81%
5 Industrials 3.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LSCC icon
251
Lattice Semiconductor
LSCC
$16.5B
$1.6M 0.04%
10,449
+1,409
+16% +$182K
VERA icon
252
Vera Therapeutics
VERA
$2.59B
$1.59M 0.04%
37,062
-8,410
-18% -$313K
CRSP icon
253
CRISPR Therapeutics
CRSP
$5.39B
$1.59M 0.04%
29,083
-11,926
-29% -$629K
LYV icon
254
Live Nation Entertainment
LYV
$40.4B
$1.58M 0.04%
8,642
+1,944
+29% +$320K
PPG icon
255
PPG Industries
PPG
$25B
$1.58M 0.04%
12,995
+6,557
+102% +$730K
BMY icon
256
Bristol-Myers Squibb
BMY
$136B
$1.57M 0.04%
27,302
+682
+3% +$39.2K
UNP icon
257
Union Pacific
UNP
$172B
$1.56M 0.04%
5,752
+172
+3% +$45.2K
LOW icon
258
Lowe's Companies
LOW
$115B
$1.56M 0.04%
7,081
+42
+0.6% +$9.54K
INSM icon
259
Insmed
INSM
$27.6B
$1.56M 0.04%
14,602
-13,335
-48% -$1.61M
IBRX icon
260
ImmunityBio
IBRX
$8.56B
$1.55M 0.04%
176,503
-66,505
-27% -$503K
DE icon
261
Deere & Co
DE
$187B
$1.54M 0.04%
2,433
+63
+3% +$36.5K
ACAD icon
262
Acadia Pharmaceuticals
ACAD
$4.83B
$1.54M 0.04%
60,817
-23,708
-28% -$522K
BHP icon
263
BHP
BHP
$230B
$1.54M 0.04%
18,435
+1,331
+8% +$110K
MDGL icon
264
Madrigal Pharmaceuticals
MDGL
$12.5B
$1.53M 0.04%
2,850
-2,012
-41% -$1.03M
TCOM icon
265
Trip.com Group
TCOM
$25.8B
$1.52M 0.04%
38,227
-931
-2% -$46.2K
UBER icon
266
Uber
UBER
$155B
$1.52M 0.04%
21,023
+363
+2% +$26.6K
PAAS icon
267
Pan American Silver
PAAS
$21.3B
$1.5M 0.04%
33,569
-12,074
-26% -$647K
QURE icon
268
uniQure
QURE
$3.09B
$1.49M 0.04%
32,331
-7,019
-18% -$184K
BBIO icon
269
BridgeBio Pharma
BBIO
$14.6B
$1.48M 0.04%
19,929
-10,448
-34% -$732K
NUVL
270
DELISTED
Nuvalent
NUVL
$1.48M 0.04%
11,992
-8,553
-42% -$920K
NOW icon
271
ServiceNow
NOW
$146B
$1.48M 0.04%
14,868
+1,916
+15% +$190K
CPRX
272
DELISTED
Catalyst Pharmaceutical
CPRX
$1.47M 0.04%
46,789
-10,755
-19% -$317K
CVS icon
273
CVS Health
CVS
$124B
$1.47M 0.04%
14,213
-3
-0% -$268
SMMT icon
274
Summit Therapeutics
SMMT
$14B
$1.46M 0.04%
100,549
-12,377
-11% -$219K
IONS icon
275
Ionis Pharmaceuticals
IONS
$9.65B
$1.45M 0.04%
18,321
-7,966
-30% -$599K

Similar funds

Profund Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, Profund Advisors held 1,250 positions worth $3.64B, up 34% from $2.72B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Profund Advisors deployed $245M of net new capital in Q2 2026, opening 158 new positions and adding to 429 existing holdings. Its largest new stake was Honeywell Aerospace: 24,902 shares worth $5.51M.

By sector, the portfolio is most concentrated in Technology at 56% of assets, up from 43% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Honeywell, an estimated $5.34M trimmed.

  • Profund Advisors's largest Q2 2026 buy was Honeywell Aerospace: 24,902 shares worth $5.51M.
  • Profund Advisors added most to NVIDIA in Q2 2026, an estimated $72.2M increase.
  • Profund Advisors's biggest Q2 2026 reduction was Honeywell, cutting an estimated $5.34M.
  • Profund Advisors fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $3.27M.
  • Profund Advisors's ten largest holdings make up 41% of its $3.64B portfolio in Q2 2026.
  • Profund Advisors opened 158 new positions and closed 75 in Q2 2026.
  • Profund Advisors's portfolio value rose 34% quarter-over-quarter to $3.64B.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.